COVID-19
-
May 16, 2022
Multiple outpatient treatment options for COVID-19, including Paxlovid™
-
May 12, 2022
VUMC-led study finds Moderna COVID vaccine safe and effective for children
-
May 10, 2022
Report lays out solution for pandemic patient privacy
Health information privacy experts at Vanderbilt University Medical Center, the University of Texas at Dallas and IBM have collaborated on a public case reporting framework keyed to the dynamics of pandemics. -
May 10, 2022
Resistance to COVID-19 drug detected in lab study
Vanderbilt research shows that the virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism. -
May 5, 2022
COVID-associated bleeding risk
While case reports have noted acquired hemophilia after COVID-19 infection or vaccination, a new study finds no increased risk. -
April 25, 2022
VUMC offers second booster to eligible individuals
-
April 14, 2022
VUMC research team receives $1 million grant from AHA to study impact of long-COVID on heart
A research team led by Cyndya Shibao, MD, MSCI, associate professor of Medicine at Vanderbilt University Medical Center (VUMC), has received a three-year, $1-million grant from the American Heart Association to study long-term effects of COVID-19 on the heart and cardiovascular system.